Home/Filings/4/0001209191-20-016169
4//SEC Filing

Ragatz William 4

Accession 0001209191-20-016169

CIK 0001734517other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:51 PM ET

Size

6.0 KB

Accession

0001209191-20-016169

Insider Transaction Report

Form 4
Period: 2020-03-02
Ragatz William
VP, Head of Commercial
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-03-02+50,54850,548 total
    Exercise: $41.10Exp: 2030-03-01Common Stock (50,548 underlying)
Holdings
  • Common Stock

    16,250
Footnotes (1)
  • [F1]This option grant vests as to 25% of the shares on March 2, 2021 with the remainder vesting in equal installments every three months thereafter and ending on March 2, 2024.

Issuer

Viela Bio, Inc.

CIK 0001734517

Entity typeother

Related Parties

1
  • filerCIK 0001789298

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:51 PM ET
Size
6.0 KB